Kawasaki, Japan

Munetaka Tokumasu



 

Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 81(Granted Patents)


Location History:

  • Kanagawa, JP (2003 - 2013)
  • Kawasaki, JP (2004 - 2017)
  • Chuo-ku, JP (2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Inventor Profile: Munetaka Tokumasu

Introduction

Munetaka Tokumasu is a prominent inventor based in Kawasaki, Japan, known for his significant contributions to the field of pharmaceutical chemistry. With a total of 16 patents to his name, he has dedicated his career to the development of innovative compounds that target critical medical conditions. His work showcases a profound understanding of integrin activity and diabetes treatment.

Latest Patents

Among his latest patents, two stand out for their potential therapeutic applications. The first patent involves "Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity." This innovation presents a compound with α4 integrin inhibitory action. The compound is characterized as a sulfonamide derivative represented by a specific formula, which includes various substituents defined in the specification. Another notable patent is related to a "Heteroarylcarboxylic acid ester derivative," which details compounds with therapeutic potential as hyperglycemic inhibitors and serine protease inhibitors, aimed at providing new solutions for diabetes treatment.

Career Highlights

Munetaka Tokumasu has had an impressive career, marked by his involvement with leading companies in the pharmaceutical industry. He has worked with Ajinomoto Co., Ltd. and Ea Pharma Co., Ltd., contributing his expertise to the development of groundbreaking therapeutic compounds. His innovative mindset and dedication to research have established him as a valuable asset in the field.

Collaborations

Throughout his career, Tokumasu has collaborated with esteemed colleagues, including Tamotsu Suzuki and Tadakiyo Nakagawa. These collaborations have fostered an environment of shared knowledge and innovation, enabling the development of advanced therapeutic solutions that address pressing healthcare challenges.

Conclusion

Munetaka Tokumasu's work exemplifies the spirit of innovation within the pharmaceutical sector. His impressive array of patents, particularly in integrin inhibition and diabetes treatment, underscores his commitment to improving health outcomes. As he continues to innovate and collaborate, Tokumasu remains an influential figure in the world of patentable inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…